FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912691281> ?p ?o ?g. }

• W2912691281 endingPage "3034" @default.
• W2912691281 startingPage "3026" @default.
• W2912691281 abstract "Abstract Purpose: PD-(L)1–blocking antibodies have clinical activity in metastatic non–small cell lung cancer (NSCLC) and mediate durable tumor remissions. However, the majority of patients are resistant to PD-(L)1 blockade. Understanding mechanisms of primary resistance may allow prediction of clinical response and identification of new targetable pathways. Experimental Design: Peripheral blood mononuclear cells were collected from 35 patients with NSCLC receiving nivolumab monotherapy. Cellular changes, cytokine levels, gene expression, and polymorphisms were compared between responders and nonresponders to treatment. Findings were confirmed in additional cohorts of patients with NSCLC receiving immune checkpoint blockade. Results: We identified a genetic variant of a killer cell immunoglobulin-like receptor (KIR) KIR3DS1 that is associated with primary resistance to PD-1 blockade in patients with NSCLC. This association could be confirmed in independent cohorts of patients with NSCLC. In a multivariate analysis of the pooled cohort of 135 patients, the progression-free survival was significantly associated with presence of the KIR3DS1 allele (HR, 1.72; 95% confidence interval, 1.10–2.68; P = 0.017). No relationship was seen in cohorts of patients with NSCLC who did not receive immunotherapy. Cellular assays from patients before and during PD-1 blockade showed that resistance may be due to NK-cell dysfunction. Conclusions: We identified an association of the KIR3DS1 allelic variant with response to PD-1–targeted immunotherapy in patients with NSCLC. This finding links NK cells with response to PD-1 therapy. Although the findings are interesting, a larger analysis in a randomized trial will be needed to confirm KIRs as predictive markers for response to PD-1–targeted immunotherapy." @default.
• W2912691281 created "2019-02-21" @default.
• W2912691281 creator A5007155024 @default.
• W2912691281 creator A5014147265 @default.
• W2912691281 creator A5017224763 @default.
• W2912691281 creator A5019660943 @default.
• W2912691281 creator A5021524724 @default.
• W2912691281 creator A5027425743 @default.
• W2912691281 creator A5034706637 @default.
• W2912691281 creator A5044032162 @default.
• W2912691281 creator A5044986640 @default.
• W2912691281 creator A5051330037 @default.
• W2912691281 creator A5051474349 @default.
• W2912691281 creator A5054718110 @default.
• W2912691281 creator A5064212856 @default.
• W2912691281 creator A5064779191 @default.
• W2912691281 creator A5066477976 @default.
• W2912691281 creator A5068350308 @default.
• W2912691281 creator A5070723609 @default.
• W2912691281 creator A5071402164 @default.
• W2912691281 creator A5084751312 @default.
• W2912691281 creator A5087984672 @default.
• W2912691281 creator A5088400718 @default.
• W2912691281 creator A5090698825 @default.
• W2912691281 creator A5090761384 @default.
• W2912691281 creator A5091525933 @default.
• W2912691281 date "2019-05-15" @default.
• W2912691281 modified "2023-10-03" @default.
• W2912691281 title "A Variant of a Killer Cell Immunoglobulin-like Receptor Is Associated with Resistance to PD-1 Blockade in Lung Cancer" @default.
• W2912691281 cites W1822086652 @default.
• W2912691281 cites W1980701461 @default.
• W2912691281 cites W1981815217 @default.
• W2912691281 cites W1996408493 @default.
• W2912691281 cites W2007509667 @default.
• W2912691281 cites W2007542983 @default.
• W2912691281 cites W2049553585 @default.
• W2912691281 cites W2062581776 @default.
• W2912691281 cites W2081609875 @default.
• W2912691281 cites W2104347254 @default.
• W2912691281 cites W2106747061 @default.
• W2912691281 cites W2108234281 @default.
• W2912691281 cites W2138207763 @default.
• W2912691281 cites W2143772132 @default.
• W2912691281 cites W2156353875 @default.
• W2912691281 cites W2169482269 @default.
• W2912691281 cites W2198093519 @default.
• W2912691281 cites W2293531514 @default.
• W2912691281 cites W2341800449 @default.
• W2912691281 cites W2476725372 @default.
• W2912691281 cites W2490333234 @default.
• W2912691281 cites W2515812752 @default.
• W2912691281 cites W2527905628 @default.
• W2912691281 cites W2578528809 @default.
• W2912691281 cites W2609243345 @default.
• W2912691281 cites W2615393228 @default.
• W2912691281 cites W2734574921 @default.
• W2912691281 cites W2753065806 @default.
• W2912691281 cites W2758987079 @default.
• W2912691281 cites W2772677509 @default.
• W2912691281 cites W2774712455 @default.
• W2912691281 cites W2787835497 @default.
• W2912691281 cites W2808909747 @default.
• W2912691281 doi "https://doi.org/10.1158/1078-0432.ccr-18-3041" @default.
• W2912691281 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30765392" @default.
• W2912691281 hasPublicationYear "2019" @default.
• W2912691281 type Work @default.
• W2912691281 sameAs 2912691281 @default.
• W2912691281 citedByCount "29" @default.
• W2912691281 countsByYear W29126912812019 @default.
• W2912691281 countsByYear W29126912812020 @default.
• W2912691281 countsByYear W29126912812021 @default.
• W2912691281 countsByYear W29126912812022 @default.
• W2912691281 countsByYear W29126912812023 @default.
• W2912691281 crossrefType "journal-article" @default.
• W2912691281 hasAuthorship W2912691281A5007155024 @default.
• W2912691281 hasAuthorship W2912691281A5014147265 @default.
• W2912691281 hasAuthorship W2912691281A5017224763 @default.
• W2912691281 hasAuthorship W2912691281A5019660943 @default.
• W2912691281 hasAuthorship W2912691281A5021524724 @default.
• W2912691281 hasAuthorship W2912691281A5027425743 @default.
• W2912691281 hasAuthorship W2912691281A5034706637 @default.
• W2912691281 hasAuthorship W2912691281A5044032162 @default.
• W2912691281 hasAuthorship W2912691281A5044986640 @default.
• W2912691281 hasAuthorship W2912691281A5051330037 @default.
• W2912691281 hasAuthorship W2912691281A5051474349 @default.
• W2912691281 hasAuthorship W2912691281A5054718110 @default.
• W2912691281 hasAuthorship W2912691281A5064212856 @default.
• W2912691281 hasAuthorship W2912691281A5064779191 @default.
• W2912691281 hasAuthorship W2912691281A5066477976 @default.
• W2912691281 hasAuthorship W2912691281A5068350308 @default.
• W2912691281 hasAuthorship W2912691281A5070723609 @default.
• W2912691281 hasAuthorship W2912691281A5071402164 @default.
• W2912691281 hasAuthorship W2912691281A5084751312 @default.
• W2912691281 hasAuthorship W2912691281A5087984672 @default.
• W2912691281 hasAuthorship W2912691281A5088400718 @default.
• W2912691281 hasAuthorship W2912691281A5090698825 @default.
• W2912691281 hasAuthorship W2912691281A5090761384 @default.
• W2912691281 hasAuthorship W2912691281A5091525933 @default.

• next